This 4th Biologics and Biosimilars Congress 2018 is a conference will provide in-depth studies of antibody therapeutics, biotherapeutic development and biologics for immunotherapy, including oncology and treatment of autoimmune disease and an expanded session on Antibody-Drug Conjugates, as well as a session examining recent clinical and regulatory developments in biosimilars.
The 4th Biologics and Biosimilars Congress 2018 covers topics such as: